1/1

2 files

Preventing the development of severe COVID-19 by modifying immunothrombosis

journal contribution

posted on 2021-01-01, 00:00 authored by G Morris, Chiara BortolasciChiara Bortolasci, B K Puri, Lisa OliveLisa Olive, Wolf MarxWolf Marx, Adrienne O'NeilAdrienne O'Neil, Eugene AthanEugene Athan, A Carvalho, M Maes, Ken WalderKen Walder, Michael BerkMichael Berk

Preventing the development of severe COVID-19 by modifying immunothrombosis

History

Journal

Life sciences

Volume

264

Article number

118617

Pagination

1 - 15

Publisher

Elsevier

Location

Amsterdam, The Netherlands

Publisher DOI

https://doi.org/10.1016/j.lfs.2020.118617

Link to full text

https://doi.org/10.1016/j.lfs.2020.118617

ISSN

0024-3205

eISSN

1879-0631

Language

eng

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000600546400018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Categories

No categories selected

Keywords

Science & Technology Life Sciences & Biomedicine Medicine, Research & Experimental Pharmacology & Pharmacy Research & Experimental Medicine COVID-19 SARS-CoV-2 Respiratory infection Treatment NF-KAPPA-B ACETYL-L-CYSTEINE OBSTRUCTIVE PULMONARY-DISEASE RESPIRATORY-DISTRESS-SYNDROME ACUTE LUNG INJURY ASPIRIN-TRIGGERED LIPOXINS VITAMIN-C PHARMACOKINETICS BRONCHIAL EPITHELIAL-CELLS OXIDATIVE STRESS MARKERS ZINC TRANSPORTER ZIP14

Licence

All Rights Reserved

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC